Regulation 172 Parallel import licences

United Kingdom

(1)

The prohibitions in regulation 46 (requirement for authorisation) do not prevent—

(a)

the holder of a parallel import licence from placing the medicinal product to which the licence relates on the market; or

(b)

the sale or supply, or offer for sale or supply, of a medicinal product to which a parallel import licence relates, in accordance with the terms of that licence.

F1(2)

In this regulation “parallel import licence” has the same meaning as in regulation 48(2).

Annotations

Textual amendments

F1: Reg. 172(2) substituted (E.W.S.) (1.10.2014) by The Human Medicines (Amendment) (No. 2) Regulations 2014 (S.I. 2014/1878), regs. 1, 18 and reg. 172(2) substituted (N.I.) (1.10.2014) by The Human Medicines (Amendment) (No. 2) Regulations 2014 (S.R. 2014/324), regs. 1(1), 18